In pRCC2 tumors, we observed a SMARCB1 driver mutation in one pRCC2; TERT promoter in two pRCC2; SETD2, PBRM1 and NF2 in one pRCC2 tumor each. The gene discussed is NF2; the disease is neoplasm.